For in-vitro laboratory research use only. Not for human consumption. Not a medicinal product.
Tesamorelin 10mg
GHRH analogue — the only peptide with existing pharmaceutical approval. Reduces visceral adipose tissue.
Select Quantity / Format
Tesamorelin is a stabilised GHRH analogue that stimulates endogenous growth hormone release from the pituitary. It is the only peptide in its class to hold pharmaceutical approval (for HIV-associated lipodystrophy), making it one of the most clinically validated GHRH compounds available for research.
- Only GHRH analogue with pharmaceutical approval
- Reduces visceral adipose accumulation specifically
- Stimulates pulsatile GH release
- Does not suppress endogenous GH production
- 10mg lyophilised vial — research grade
Research Use Only. This product is sold strictly for in-vitro laboratory research purposes. It is not intended for human or veterinary consumption, is not a medicine or dietary supplement, and is not approved by the MHRA or any regulatory authority for therapeutic use. It is not intended to diagnose, treat, cure, or prevent any disease or condition.